BRCA1 Linked to Brain Size

The breast cancer-associated gene may play a protective role in neural stem cells, a mouse study finds.

Written byRina Shaikh-Lesko
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, RAMAThe BRCA1 gene, most famous for its link to breast cancer risk, may also play a role in neural development and influence brain size, according to a study published this week (March 17) in PNAS. Researchers have long known that BRCA1-knockout mice die soon after birth, but did not fully understand why.

A team led by Inder Verma of the Salk Institute for Biological Studies in La Jolla, California, had previously seen that BRCA1 is highly expressed in the neuroectoderm, which is populated with neural stem cells. So the researchers engineered mice in which BRCA1 was knocked out in just the neural stem cells. They found that the brains of these mice were a third the size of normal mouse brains, and had especially small regions for learning, memory, motor control and sensation. Mature mutant mice had severe ataxia.

Upon closer inspection, the researchers found that neural stem cells were dying off at a high rate. They showed that BRCA1 prevented DNA breaks and that without it, excessive DNA damage triggered cell destruction. Brain cells that did survive looked like disorganized and deformed cancer cells.

“This is important fundamental basic science about how the genome is protected in rapidly proliferating cells in the brain,” Huda Zoghbi, a neuroscientist at Baylor College of Medicine in Houston, Texas, who was not involved with the study, told ScienceNOW.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies